DDI Logo

Tag Archives: October 2019 Newsletter

It’s that time of year again! Medicare D Notice and Filing Reminder

All employers, large and small, who offer prescription drug coverage are required to inform their employees and CMS if their prescription drug plan is Medicare creditable by October 15, 2019. This deadline is a result of the annual enrollment period for Medicare which is October 15 – December 7th each year. Even if you are unsure of Medicare eligibility it is recommended to provide this notice to your benefit eligible employees and their dependents.

Please click here for the full explanation of the Medicare Modernization Act’s requirements as well as model notices of the required forms. Any members (including dependents) who are eligible or will be eligible within the next year for Medicare must receive the notice. Employers must also notify CMS via their online form as to whether their plans are or are not creditable.

According to CMS:

This disclosure must be provided to Medicare eligible active working individuals and their dependents, Medicare eligible COBRA individuals and their dependents, Medicare eligible disabled individuals covered under your prescription drug plan and any retirees and their dependents. The MMA imposes a late enrollment penalty on individuals who do not maintain creditable coverage for a period of 63 days or longer following their initial enrollment period for the Medicare prescription drug benefit.
Click here to download the model notice letters you can customize and send to employees. If you are unsure whether your plan is creditable or not, please contact your health insurance carrier or DDI. Most carriers recently sent notices to clients indicating if the plan was creditable. Also, you need to re-evaluate the creditability of your prescription plan if you make changes at your plan’s renewal, and notify your employees accordingly.


Please Note:

If you are a DDI Administration / Outsourcing client, we have sent this letter to your employees on your behalf.

Please call us with any questions.

Preview of 2020 small group and individual monthly rates:

PacificSource, Kaiser, Providence and MODA lead the individual market, and Kaiser, Regence, and Providence continue to lead the small group market… Please note that these are only averages as reported by the Oregon Department of Consumer & Business Services, and your rates may vary.  Click here for an overview of the Final rate decisions released for 2020 health plans in Oregon.  Continue Reading

DDI Logo

2111 NE Halsey Street

Portland, OR 97232

503.206.5654

fax 503.296.2585

info@ddibenefits.com

Services for Employers

Employee Benefits / Insurance Consulting

Open Enrollment / Employee Engagement

Benefits Administration

Benefits / HR Technology

Compliance Administration

HR Support

Wellness

Services for Individuals

Health Insurance

Dental insurance

Life Insurance

Medicare

Medicare Disclaimer: We do not offer every plan available in your area. Currently, we represent 7 organizations which offer 35 products in Oregon and Washington. Please contact medicare.gov or 1-800-MEDICARE, or your local State Health Insurance Program to get information on all your options. Please note that we are required to record all phone conversations with clients who want to discuss Medicare Advantage and/or Part D prescription drug plans. We are not connected with or endorsed by the United States government or the federal Medicare program.

DDI Logo

2111 NE Halsey Street

Portland, OR 97232

503.206.5654

fax 503.296.2585

info@ddibenefits.com


Privacy Policy

Medicare Disclaimer: We do not offer every plan available in your area. Currently, we represent 7 organizations which offer 35 products in Oregon and Washington. Please contact medicare.gov or 1-800-MEDICARE, or your local State Health Insurance Program to get information on all your options. Please note that we are required to record all phone conversations with clients who want to discuss Medicare Advantage and/or Part D prescription drug plans. We are not connected with or endorsed by the United States government or the federal Medicare program.